510(k) Report

510(k) · Cleared

Cleared

Sonicaid System 8002

K992607510(k) TraditionalCleared Apr 27, 2001633-day reviewClass II21 CFR 884.2740

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oxford Instruments Medical Systems · HGM System, Monitoring, Perinatal

Cleared on Apr 27, 2001 as substantially equivalent to K912639 (Oxford Medilog, Inc., 1991) after a 633-day review. Its family tree reaches back 1 generation to 1991. 28 later devices descend from it.

Decided
Apr 27, 2001
Review
633 days
Class
Class II
Product code
HGM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K912639 (1991). 28 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2006: 1 descendant cleared2008: 1 descendant cleared2013: 1 descendant cleared2015: 1 descendant cleared2007: 1 descendant cleared2011: 1 descendant cleared2016: 1 descendant cleared2018: 1 descendant cleared2019: 3 descendants cleared2017: 1 descendant cleared2023: 5 descendants cleared2020: 1 descendant cleared2024: 3 descendants cleared2022: 2 descendants cleared2025: 4 descendants cleared2026: 1 descendant clearedK912639 · Sonicaid Team · Oxford Medilog, Inc. · 19911990200020102020
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 5 descendants3 generations forward: 3 descendants4 generations forward: 3 descendants5 generations forward: 2 descendants6 generations forward: 1 descendant7 generations forward: 3 descendants8 generations forward: 6 descendants9 generations forward: 3 descendants K912639 · Sonicaid Team · Oxford Medilog, Inc. · 19910+5
  1. Root · 1 generation backK912639 Sonicaid TeamOxford Medilog, Inc. · 1991
  2. This deviceK992607 Sonicaid System 8002Oxford Instruments Medical Systems · 2001
  3. Descendant · cites it directly · 22 of its ownK081140 VisensiaObs Medical · 2008
  4. Descendant · 2 generations on · 17 of its ownK110953 Visensia, Visensia with AlertObs Medical · 2011
  5. Descendant · 2 generations on · 16 of its ownK152258 T3 SoftwareEtiometry, Inc. · 2016
  6. Descendant · 3 generations on · 15 of its ownK163065 T3 SoftwareEtiometry, Inc. · 2017
  7. Descendant · 4 generations on · 14 of its ownK190273 T3 Platform softwareEtiometry, Inc. · 2019

Showing 5 of 28 descendants. See all descendants

Descendants cleared per year

2006: 12007: 12008: 12011: 12013: 12015: 12016: 12017: 12018: 12019: 32020: 12022: 22023: 52024: 32025: 42026: 1
2006high 5 (2023) · low 0 (2009)2026

Most influential descendants

Showing 5 of 28 · See all
  • K081140VisensiaObs Medical · 2008 · cites it directly22descendants
  • K110953Visensia, Visensia with AlertObs Medical · 2011 · 2 generations on17descendants
  • K152258T3 SoftwareEtiometry, Inc. · 2016 · 2 generations on16descendants
  • K163065T3 SoftwareEtiometry, Inc. · 2017 · 3 generations on15descendants
  • K190273T3 Platform softwareEtiometry, Inc. · 2019 · 4 generations on14descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K912639Sonicaid TeamOxford Medilog, Inc.1991—
0 (this device)K992607Sonicaid System 8002Oxford Instruments Medical Systems2001—
+1K081140VisensiaObs Medical2008—
+2K110953Visensia, Visensia with AlertObs Medical2011—
+2K152258T3 SoftwareEtiometry, Inc.2016—
+3K163065T3 SoftwareEtiometry, Inc.2017—
+4K190273T3 Platform softwareEtiometry, Inc.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200710
200810
201110
201310
201510
201610
201710
201810
201930
202010
202220
202350
202430
202540
202610
FIG. 1 — Lineage of K992607, 1991–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HGM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HGM device

  1. #1 K241882 Fetal & Maternal Monitor (F15A, F15A Air)score 19.5 · 33 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K912639Sonicaid Team
Summary page 2
…, Doppler evaluations, and/or biophysical profile. 4, Substantia) Equivalence The Sonicaid® System 8002 is substantially equivalent to the Sonicaid® Team fetal monitor K912639. S. Performance Studies The Sonicaid® System 8002 informs the clinician whether a CTG meets a number of criteria that are indic…
Oxford Medilog, Inc.1991—

What descends from it? (28)

See all 28

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081140VisensiaObs Medical200822
K053112BiosignOxford Biosignals Limited20068

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K081140 (Obs Medical, 2008) has gone furthest, with 22 descendants of its own.

How does its category compare?

All HGM devices

HGM System, Monitoring, Perinatal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HGM

4in 2025

2007: 32008: 42009: 42010: 42011: 132012: 42013: 22014: 42015: 52016: 12017: 32018: 32020: 12022: 12023: 22024: 12025: 42026 (partial year): 2
2007high 13 (2011) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HGM

269in 2025

2007: 56 days median2008: 75 days median2009: 66 days median2010: 193 days median2011: 141 days median2012: 107 days median2014: 231 days median2015: 169 days median2017: 138 days median2018: 258 days median2025: 269 days median
2007high 269 (2025) · low 56 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HGM

5in 2019

2008: 42009: 62013: 12014: 12019: 52026 (partial year): 2
2007high 6 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HGM

99in 2025

2007: 352008: 172009: 422010: 642011: 832012: 442013: 162014: 302015: 442016: 172017: 272018: 302019: 412020: 192021: 712022: 872023: 692024: 1742025: 99
2007high 174 (2024) · low 16 (2013)2025

MAUDE reports naming product code HGM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007356035
2008475417
2009466642
20104193064
201113141083
20124107044
20132—116
20144231130
20155169044
20161—017
20173138027
20183258030
20190—541
20201—019
20210—071
20221—087
20232—069
20241—0174
20254269099
20262—2—

What is it indicated for?

The Sénicaid System 8002 is for use in pregnancies from 32 weeks gestation onwards. It can be used on women who are experiencing Braxton-Hicks contractions but is not suitable for use in established labour as the fetus is then exposed to additional factors such as labour contractions, pharmacological agents, epidural anaesthesia, and the possibility of fetal infection secondary to ruptured membranes. Typical indications for use include the following: —…

Read the full statement (149 words)

The Sénicaid System 8002 is for use in pregnancies from 32 weeks gestation onwards. It can be used on women who are experiencing Braxton-Hicks contractions but is not suitable for use in established labour as the fetus is then exposed to additional factors such as labour contractions, pharmacological agents, epidural anaesthesia, and the possibility of fetal infection secondary to ruptured membranes. Typical indications for use include the following:

— previous questionable fetal heart rate recordings or poor obstetric history

_ abnormal umbilical blood flow velocity waveforms

— suspected fetal anomalies

— suspicion of maternal intoxication or assault

— intrauterine growth retardation

— antepartum haemorrhage

— uterine pain

— reduced fetal movements

— hypertension or pre-eclampsia

— reduced amniotic fluid volume

The Sonicaid System 8002 is used as an adjunct to and is not intended to replace or substitute for assessment of amniotic fluid amount, Doppler evaluations, and/or biophysical profile.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K992607: Sonicaid System 8002.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K992607

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026